Cephalon Reports Continued Strong Earnings Growth
home > MSN news
... Sales of PROVIGIL(R)(modafinil) Tablets [C-IV] increased 6 percent to $100.1 million ... result of recent acquisitions. PROVIGIL, ACTIQ, and GABITRIL each experienced double-digit ...
- link to Cephalon Reports Continued Strong Earnings Growth -
Last update: 05/26/2005